haematology
Blood cancers

Myeloma, CLL patients have weakened response to COVID-19 vaccination

Vaccination against COVID-19 may produce a weaker immune response in patients with some haematological malignancies, according to several new studies. With both multiple myeloma (MM) and chronic lymphocytic leukaemia (CLL), antibody responses appear lower after vaccination than in the general population. In one study, a total of 93 patients with MM at one UK centre ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic